Experimental Clinical Chemistry, Department of Laboratory Medicine, Lund University, Skåne University Hospital, Malmö, Sweden.
Center for Molecular Pathology, Department of Laboratory Medicine, CREATE Health, Lund University, Skåne University Hospital, Malmö, Sweden.
Oncogene. 2014 Nov 13;33(46):5360-9. doi: 10.1038/onc.2013.479. Epub 2013 Nov 11.
PI3-kinase has a crucial role in transformation mediated by the oncogenic c-Kit mutant D816V. In this study, we demonstrate that the c-Kit/D816V-mediated cell survival is dependent on an intact direct binding of PI3-kinase to c-Kit. However, mutation of this binding site had little effect on the PI3-kinase activity in the cells, suggesting that c-Kit/D816V-mediated cell survival is dependent on PI3-kinase but not its kinase activity. Furthermore, inhibition of the lipid kinase activity of PI3-kinase led only to a slight inhibition of cell survival. Knockdown of the predominant PI3-kinase isoform p110δ in c-Kit/D816V-expressing Ba/F3 cells led to reduced cell transformation both in vitro and in vivo without affecting the overall PI3-kinase activity. This suggests that p110δ has a lipid-kinase-independent role in c-Kit/D816V-mediated cell transformation. We furthermore demonstrate that p110δ is phosphorylated at residues Y524 and S1039 and that phosphorylation requires an intact binding site for PI3-kinase in c-Kit/D816V. Overexpression of p110δ carrying the Y523F and S1038A mutations significantly reduced c-Kit/D816V-mediated cell survival and proliferation. Taken together, our results demonstrate an important lipid-kinase-independent role of p110δ in c-Kit/D816V-mediated cell transformation. This furthermore suggests that p110δ could be a potential diagnostic factor and selective therapeutic target for c-Kit/D816V-expressing malignancies.
PI3-激酶在致癌 c-Kit 突变体 D816V 介导的转化中起着至关重要的作用。在这项研究中,我们证明 c-Kit/D816V 介导的细胞存活依赖于 PI3-激酶与 c-Kit 的直接结合。然而,该结合位点的突变对细胞中的 PI3-激酶活性几乎没有影响,这表明 c-Kit/D816V 介导的细胞存活依赖于 PI3-激酶而不是其激酶活性。此外,抑制 PI3-激酶的脂质激酶活性仅导致细胞存活的轻微抑制。在表达 c-Kit/D816V 的 Ba/F3 细胞中敲低主要的 PI3-激酶同工型 p110δ 会导致体外和体内的细胞转化减少,而不影响整体 PI3-激酶活性。这表明 p110δ 在 c-Kit/D816V 介导的细胞转化中具有脂质激酶非依赖性作用。我们进一步证明 p110δ 在 Y524 和 S1039 残基处发生磷酸化,并且磷酸化需要 c-Kit/D816V 中 PI3-激酶的完整结合位点。表达携带 Y523F 和 S1038A 突变的 p110δ 的过表达显著降低了 c-Kit/D816V 介导的细胞存活和增殖。总之,我们的结果表明 p110δ 在 c-Kit/D816V 介导的细胞转化中具有重要的脂质激酶非依赖性作用。这进一步表明 p110δ 可能是表达 c-Kit/D816V 的恶性肿瘤的潜在诊断因子和选择性治疗靶点。